Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multi-center, Double-blind, Placebo-controlled Trial of Danhong Injection in the Treatment of Acute Ischemic Stroke

NCT01677208 is registered in ClinicalTrials.gov with China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT01677208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01677208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multi-center, Double-blind, Placebo-controlled Trial of Danhong Injection in the Treatment of Acute Ischemic Stroke
Lead sponsor
China Academy of Chinese Medical Sciences
Phase
Phase 4
Overall status
Completed
Start date
March 13, 2013
Completion date
March 27, 2019
Enrollment
1,503 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke